NasdaqGS - Nasdaq Real Time Price USD

Viatris Inc. (VTRS)

8.13

+0.10

+(1.25%)

At close: April 25 at 4:00:00 PM EDT

8.12

-0.01

(-0.12%)

After hours: April 25 at 7:15:31 PM EDT

Viatris Inc. (VTRS): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other Billionaire Ken Fisher’s healthcare stock picks with massive upside potential. The healthcare industry, an essential component of global well-being and […]

Insider Monkey 10 hours ago

VTRS
+1.25%
Viatris to Present at the BofA Securities 2025 Healthcare Conference

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, will present at the BofA Securities 2025 Healthcare Conference in Las Vegas, NV, on Tuesday, May 13, 2025. The company's presentation will begin at 5 p.m. PT / 8 p.m. ET.

PR Newswire 2 days ago

VTRS
+1.25%
3 Reasons VTRS is Risky and 1 Stock to Buy Instead

Viatris’s stock price has taken a beating over the past six months, shedding 33% of its value and falling to $7.69 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.

StockStory 3 days ago

VTRS
+1.25%
Is Viatris Inc. (NASDAQ:VTRS) the Best Cheap Stock to Buy Under $10?

We recently published a list of the 10 Best Cheap Stocks to Buy Under $10. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other cheap stocks to buy under $10. On April 21, Tom Lee, Fundstrat CIO, co-founder, and managing partner, joined ‘Squawk Box’ on CNBC […]

Insider Monkey 4 days ago

VTRS
+1.25%
Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has filed applications to the Ministry of Health, Labor and Welfare (MHLW) for approval of Effexor SR Capsules (venlafaxine hydrochloride), a serotonin-noradrenaline reuptake inhibitor (SNRI) to treat adults with generalized anxiety disorder (GAD), an indication for which no other treatment option is currently approved in Japan.

PR Newswire 6 days ago

VTRS
+1.25%
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers.

StockStory 10 days ago

JAZZ

ANIP

VTRS
+1.25%
Is Viatris Inc. (VTRS) The Top Healthcare Stock to Buy According to Billionaire David Einhorn?

We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other top healthcare stocks to buy according to billionaire David Einhorn. Wall Street has come down crashing on President Donald Trump’s […]

Insider Monkey 13 days ago

VTRS
+1.25%
^GSPC

GLRE
Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer

Viatris Inc. (Nasdaq: VTRS) today announced that Hemanth J. Varghese has joined the Company as Chief Strategy Officer. Varghese will be a member of the Company's Executive Leadership Team.

PR Newswire 13 days ago

VTRS
+1.25%
Viatris Inc. (VTRS): Among the High-Dividend Stocks to Invest In Under $10

We recently published a list of the 13 High-Dividend Stocks to Invest In Under $10. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other high-dividend stocks under $10. Investors often favor dividend stocks for their long-term potential, with their appeal stemming from the consistent growth they […]

Insider Monkey 16 days ago

VTRS
+1.25%
3 Hated Stocks with Mounting Challenges

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?

StockStory 17 days ago

VTRS
+1.25%
TER

EXPO
3 Beaten-Down Stocks That Are Trading Below Their Book Values

A company's book value is equal to its total assets, less its liabilities. Book value does not consider the future at all. For investors, deals can be had when an otherwise solid company has stock trading below its book value per share (BVPS).

Motley Fool 18 days ago

VTRS
+1.25%
PLUG

JBLU
Viatris to Pay $335 Million for Settlement of Opioid-Related Claims

VTRS has reached an agreement of $335 million to resolve opioid-related claims by states, local governments, and tribes against it and certain of its subsidiaries.

Zacks 19 days ago

VTRS
+1.25%
Viatris to Pay Up to $335 Million in Opioid Settlement

Viatris will pay up to $335 million over nine years to settle opioid-related claims.

GuruFocus.com 20 days ago

VTRS
+1.25%
Viatris Statement on Nationwide Settlement to Resolve Opioid-Related Claims

Viatris Inc. (Nasdaq: VTRS) (the "Company") today announced it has reached a nationwide settlement framework to resolve opioid-related claims by states, local governments, and Tribes against the Company and certain of its subsidiaries. While the Company's presence in the U.S. opioids market is very small, the Company has agreed to this settlement to provide closure on these matters. This settlement is in no way an admission of wrongdoing or liability.

PR Newswire 20 days ago

VTRS
+1.25%
Viatris Inc. (VTRS): Among the Oversold Stocks to Buy in 2025 Amid Inflation Fears

We recently published a list of 10 Oversold Stocks to Buy in 2025 Amid Inflation Fears. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other oversold stocks to buy in 2025 amid inflation fears. The stock market continues to face significant volatility, with major indices continuing […]

Insider Monkey 28 days ago

VTRS
+1.25%
^GSPC
Viatris to Report First Quarter 2025 Financial Results on May 8, 2025

Viatris Inc. (NASDAQ: VTRS) will report first quarter 2025 financial results on Thursday, May 8, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.

PR Newswire 30 days ago

VTRS
+1.25%
Is Viatris Inc. (NASDAQ:VTRS) One of The Best Stocks to Buy According to Billionaire David Einhorn?

We recently published a list of 10 Best Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other best stocks to buy according to billionaire David Einhorn. David Einhorn is a highly regarded hedge fund manager, who co-founded Greenlight Capital in […]

Insider Monkey last month

VTRS
+1.25%
GLRE
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how pharmaceuticals stocks fared in Q4, starting with Elanco (NYSE:ELAN).

StockStory last month

ELAN

ANIP

VTRS
+1.25%
Is Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now?

We recently published a list of 12 Best Nasdaq Stocks Under $20 to Buy Now. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other best Nasdaq stocks under $20 to buy now. The Nasdaq has had a challenging start to 2025, with the index dropping nearly […]

Insider Monkey last month

VTRS
+1.25%
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at generic pharmaceuticals stocks, starting with Amphastar Pharmaceuticals (NASDAQ:AMPH).

StockStory last month

AMPH

ANIP

VTRS
+1.25%

Performance Overview

Return	VTRS	S&P 500 (^GSPC)
YTD	-33.88%	-6.06%
1-Year	-26.00%	+9.44%
3-Year	-10.60%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Viatris Inc. (VTRS)

Viatris Inc. (VTRS): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

Viatris to Present at the BofA Securities 2025 Healthcare Conference

3 Reasons VTRS is Risky and 1 Stock to Buy Instead

Is Viatris Inc. (NASDAQ:VTRS) the Best Cheap Stock to Buy Under $10?

Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Is Viatris Inc. (VTRS) The Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer

Viatris Inc. (VTRS): Among the High-Dividend Stocks to Invest In Under $10

3 Hated Stocks with Mounting Challenges

3 Beaten-Down Stocks That Are Trading Below Their Book Values

Viatris to Pay $335 Million for Settlement of Opioid-Related Claims

Viatris to Pay Up to $335 Million in Opioid Settlement

Viatris Statement on Nationwide Settlement to Resolve Opioid-Related Claims

Viatris Inc. (VTRS): Among the Oversold Stocks to Buy in 2025 Amid Inflation Fears

Viatris to Report First Quarter 2025 Financial Results on May 8, 2025

Is Viatris Inc. (NASDAQ:VTRS) One of The Best Stocks to Buy According to Billionaire David Einhorn?

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

Is Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now?

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

Performance Overview